MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73

Abstract

BackgroundMicroRNAs are non-coding RNAs which regulate a variety of cellular functions in the development of tumors. Among the numerous microRNAs, microRNA-30a (miR-30a) is thought to play an important role in the processes of various human tumors. In this study, we aimed to explore the role of miR-30a in the process of colorectal cancer (CRC).MethodsThe quantitative real-time PCR and western blot analysis were used to detect the expressions of miR-30a and CD73 in CRC cell lines and clinical tissues. The luciferase reporter assay was conducted to validate the association between miR-30a and CD73. The CCK-8, terminal deoxynucleotidyl transferase dUTP -biotin nick end labeling (TUNEL) assays and cell cycle flow cytometry were carried out to verify the biological functions of miR-30a in vitro. The nude mouse tumorigenicity experiment was used to clarify the biological role of miR-30a in vivo.ResultsThe expression of miR-30a was significantly reduced in tumor cells and tissues of CRC. The proliferation ability of CRC cells was suppressed and the apoptosis of cells was promoted when miR-30a is over-regulated, however, the biological effects would be inverse since the miR-30a is down-regulated. CD73 is thought to be a target binding gene of miR-30a because miR-30a can bind directly to the 3′-UTR of CD73 mRNA, subsequently reducing its expression. The proliferation suppression of the CRC cells mediated by miR-30a could be rescued after up-regulating the expression of CD73.ConclusionsMiR-30a plays an important role on regulating the cell proliferation and apoptosis, thus affecting the growth of the tumor in CRC. And it may participate in the disease process of CRC by regulating the expression of CD73.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-017-3291-8) contains supplementary material, which is available to authorized users.

MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2

“…Bioinformatic analysis has predicted that miRNAs may regulate over 30% of protein-coding genes (12); therefore, miRNAs play key roles in a large number of physiological and pathological processes, such as cell proliferation, cycle, apoptosis, metabolism, differentiation, motility, epithelialmesenchymal transition and metastasis (13)(14)(15)). An increasing body of evidence indicates that aberrantly expressed miRNAs are observed in almost all types of human cancer, such as CRC (16), gastric carcinoma (17), lung cancer (18) and cervical carcinoma (19). Certain miRNAs may act as oncogenes or tumour-suppressor genes which primarily depends on the roles of their target genes (20)(21)(22).…”

CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis

“…Previous studies revealed miRNA was responsible for the dysregulation of CD73 expression [30, 31]. We further investigated the potential upstream miRNA of CD73 in HCC.…”

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E

“…Recently, miR-30a was found to target NT5E in CRC ( 64 ). In this study, transfection with miR-30a reduced NT5E expression on the mRNA and on protein level and direct interaction of miR-30a with the NT5E 3′-UTR was demonstrated via luciferase reporter assays.…”